• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生命早期与肝脂肪变性相关的因素。

Factors early in life associated with hepatic steatosis.

作者信息

Quek Sabrina Xin Zi, Tan Eunice Xiang-Xuan, Ren Yi Ping, Muthiah Mark, Loo Evelyn Xiu Ling, Tham Elizabeth Huiwen, Siah Kewin Tien Ho

机构信息

Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore 119228, Singapore.

Department of Medicine, National University Hospital, Singapore 119228, Singapore.

出版信息

World J Hepatol. 2022 Jun 27;14(6):1235-1247. doi: 10.4254/wjh.v14.i6.1235.

DOI:10.4254/wjh.v14.i6.1235
PMID:35978672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9258263/
Abstract

BACKGROUND

The rise in prevalence of non-alcoholic fatty liver disease (NAFLD) mirrors the obesity epidemic. NAFLD is insidious but may gradually progress from simple steatosis to steatohepatitis, fibrosis and cirrhosis and/or hepatocellular carcinoma. Intervention strategies to ameliorate developmental programming of NAFLD may be more efficacious during critical windows of developmental plasticity.

AIM

To review the early developmental factors associated with NAFLD.

METHODS

Databases MEDLINE PubMed, and EMBASE and Reference Citation Analysis were searched and relevant publications up to April 30, 2021 were assessed. Original research studies that included risk factors associated with early development of NAFLD in human subjects were included. These factors include: Maternal factors, intrauterine and prenatal factors, post-natal factors, genetic and ethnic predisposition, childhood and adolescence environmental factors. Studies were excluded if they were review articles or animal studies, case reports or conference abstracts, or if NAFLD was not clearly defined and assessed radiologically.

RESULTS

Of 1530 citations identified by electronic search, 420 duplicates were removed. Of the 1110 citations screened from title and abstract, 80 articles were included in the final analysis. Genetic polymorphisms such as patatin-like phospholipase domain-containing protein 3 (PNPLA3) and membrane-bound O-acyltransferase domain-containing protein 7 (MBOAT7) were associated with increased risk of NAFLD. Familial factors such as maternal obesogenic environment and parental history of hepatic steatosis was associated with offspring NAFLD. Longer duration of exclusive breastfeeding in infancy was associated with a lower risk of developing NAFLD later in life while metabolic dysfunction and/or obesity in adolescence was associated with increased risk of NAFLD. Studies relating to socioeconomic factors and its association with NAFLD reported confounding results.

CONCLUSION

Maternal metabolic dysfunction during pregnancy, being exclusively breastfed for a longer time postnatally, diet and physical activity in childhood and adolescence are potential areas of intervention to decrease risk of NAFLD.

摘要

背景

非酒精性脂肪性肝病(NAFLD)患病率的上升与肥胖流行情况相似。NAFLD具有隐匿性,但可能会从单纯性脂肪变性逐渐发展为脂肪性肝炎、纤维化、肝硬化和/或肝细胞癌。在发育可塑性的关键窗口期,改善NAFLD发育编程的干预策略可能更有效。

目的

综述与NAFLD相关的早期发育因素。

方法

检索MEDLINE、PubMed和EMBASE数据库以及参考文献引用分析,并评估截至2021年4月30日的相关出版物。纳入了包括人类受试者中与NAFLD早期发展相关危险因素的原创性研究。这些因素包括:母亲因素、宫内和产前因素、产后因素、遗传和种族易感性、儿童和青少年环境因素。如果是综述文章、动物研究、病例报告或会议摘要,或者NAFLD未明确界定且未通过放射学评估,则排除这些研究。

结果

通过电子检索识别出1530条引文,去除了420条重复项。从标题和摘要中筛选出的1110条引文中,80篇文章纳入最终分析。遗传多态性,如含帕他汀样磷脂酶结构域蛋白3(PNPLA3)和含膜结合O-酰基转移酶结构域蛋白7(MBOAT7)与NAFLD风险增加相关。家族因素,如母亲的致肥胖环境和父母的肝脂肪变性病史与后代NAFLD相关。婴儿期纯母乳喂养时间较长与日后患NAFLD的风险较低相关,而青少年期的代谢功能障碍和/或肥胖与NAFLD风险增加相关。关于社会经济因素及其与NAFLD关联的研究报告了相互矛盾的结果。

结论

孕期母亲的代谢功能障碍、出生后较长时间的纯母乳喂养、儿童和青少年期的饮食及身体活动是降低NAFLD风险的潜在干预领域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/623a/9258263/880a258f8e1f/WJH-14-1235-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/623a/9258263/880a258f8e1f/WJH-14-1235-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/623a/9258263/880a258f8e1f/WJH-14-1235-g001.jpg

相似文献

1
Factors early in life associated with hepatic steatosis.生命早期与肝脂肪变性相关的因素。
World J Hepatol. 2022 Jun 27;14(6):1235-1247. doi: 10.4254/wjh.v14.i6.1235.
2
Genetics Is of the Essence to Face NAFLD.遗传学对于应对非酒精性脂肪性肝病至关重要。
Biomedicines. 2021 Sep 30;9(10):1359. doi: 10.3390/biomedicines9101359.
3
The PNPLA3 rs738409 Variant but not MBOAT7 rs641738 is a Risk Factor for Nonalcoholic Fatty Liver Disease in Obese U.S. Children of Hispanic Ethnicity.PNPLA3基因rs738409变异而非MBOAT7基因rs641738变异是美国肥胖西班牙裔儿童非酒精性脂肪性肝病的危险因素。
Pediatr Gastroenterol Hepatol Nutr. 2021 Sep;24(5):455-469. doi: 10.5223/pghn.2021.24.5.455. Epub 2021 Sep 8.
4
The Membrane-bound O-Acyltransferase7 rs641738 Variant in Pediatric Nonalcoholic Fatty Liver Disease.膜结合 O-酰基转移酶 7 rs641738 变异与儿童非酒精性脂肪性肝病。
J Pediatr Gastroenterol Nutr. 2018 Jul;67(1):69-74. doi: 10.1097/MPG.0000000000001979.
5
PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery.PNPLA3基因的p.I148M变异与减肥手术后肝脏脂肪含量的更大幅度降低有关。
Surg Obes Relat Dis. 2016 Dec;12(10):1838-1846. doi: 10.1016/j.soard.2016.06.004. Epub 2016 Jul 1.
6
Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and Therapeutics.与脂肪性肝病相关的基因变异:诊断与治疗的机遇
Biomedicines. 2023 Oct 17;11(10):2809. doi: 10.3390/biomedicines11102809.
7
Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD).遗传和表观遗传疾病修饰因子:非酒精性脂肪性肝病(NAFLD)和酒精性肝病(ALD)。
Transl Gastroenterol Hepatol. 2021 Jan 5;6:2. doi: 10.21037/tgh.2019.09.06. eCollection 2021.
8
Natural history of NASH.非酒精性脂肪性肝炎的自然史。
Liver Int. 2021 Jun;41 Suppl 1(Suppl 1):78-82. doi: 10.1111/liv.14910.
9
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models.TM6SF2/PNPLA3/MBOAT7 基因功能丧失性变异对非酒精性脂肪性肝病发生发展的影响:在患者和体外模型中的研究。
Cell Mol Gastroenterol Hepatol. 2022;13(3):759-788. doi: 10.1016/j.jcmgh.2021.11.007. Epub 2021 Nov 23.
10
Developmental Programming of NAFLD by Parental Obesity.父母肥胖导致非酒精性脂肪性肝病的发育编程
Hepatol Commun. 2020 Aug 9;4(10):1392-1403. doi: 10.1002/hep4.1578. eCollection 2020 Oct.

引用本文的文献

1
Single-cell RNA transcriptomics in mice reveals embryonic origin of fibrosis due to maternal obesity.单细胞 RNA 转录组学在小鼠中揭示了母体肥胖导致纤维化的胚胎起源。
EBioMedicine. 2024 Nov;109:105421. doi: 10.1016/j.ebiom.2024.105421. Epub 2024 Oct 30.
2
Impact of Transgenerational Nutrition on Nonalcoholic Fatty Liver Disease Development: Interplay between Gut Microbiota, Epigenetics and Immunity.代际营养对非酒精性脂肪肝病发展的影响:肠道微生物群、表观遗传学和免疫的相互作用。
Nutrients. 2024 May 3;16(9):1388. doi: 10.3390/nu16091388.
3
Postnatal Consumption of Black Bean Powder Protects against Obesity and Dyslipidemia in Male Adult Rat Offspring from Obese Pregnancies.

本文引用的文献

1
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病。
Lancet. 2021 Jun 5;397(10290):2212-2224. doi: 10.1016/S0140-6736(20)32511-3. Epub 2021 Apr 21.
2
Developmental programming of mitochondrial biology: a conceptual framework and review.线粒体生物学的发育编程:概念框架与综述。
Proc Biol Sci. 2020 May 13;287(1926):20192713. doi: 10.1098/rspb.2019.2713. Epub 2020 Apr 29.
3
Fasting C-peptide is a significant indicator of nonalcoholic fatty liver disease in obese children.空腹 C 肽是肥胖儿童非酒精性脂肪肝的重要指标。
产后食用黑豆粉可预防肥胖孕鼠雄性子代肥胖和血脂异常。
Nutrients. 2024 Apr 1;16(7):1029. doi: 10.3390/nu16071029.
4
Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases.开发用于治疗非酒精性脂肪性肝病、非酒精性脂肪性肝炎及其他代谢性疾病的肝脏X受体反向激动剂。
Front Med (Lausanne). 2023 Feb 2;10:1102469. doi: 10.3389/fmed.2023.1102469. eCollection 2023.
Diabetes Res Clin Pract. 2020 Feb;160:108027. doi: 10.1016/j.diabres.2020.108027. Epub 2020 Jan 17.
4
Association between neck circumference and non-alcoholic fatty liver disease in Mexican children and adolescents with obesity.墨西哥肥胖儿童和青少年的颈围与非酒精性脂肪性肝病之间的关联。
J Pediatr Endocrinol Metab. 2020 Feb 25;33(2):205-213. doi: 10.1515/jpem-2019-0204.
5
Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease.经活检证实的非酒精性脂肪性肝病患儿和青少年的糖尿病前期和糖尿病患病率。
J Hepatol. 2019 Oct;71(4):802-810. doi: 10.1016/j.jhep.2019.06.023. Epub 2019 Jul 4.
6
Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents.遗传风险评分对肥胖儿童和青少年肝脂肪变性的临床预测的贡献。
Dig Liver Dis. 2019 Nov;51(11):1586-1592. doi: 10.1016/j.dld.2019.05.029. Epub 2019 Jun 27.
7
Genetic and metabolic predictors of hepatic fat content in a cohort of Italian children with obesity.意大利肥胖儿童队列中肝内脂肪含量的遗传和代谢预测因子。
Pediatr Res. 2019 Apr;85(5):671-677. doi: 10.1038/s41390-019-0303-1. Epub 2019 Jan 23.
8
Update on global epidemiology of viral hepatitis and preventive strategies.全球病毒性肝炎流行病学及预防策略的最新情况
World J Clin Cases. 2018 Nov 6;6(13):589-599. doi: 10.12998/wjcc.v6.i13.589.
9
Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern.超重儿童的非酒精性脂肪肝疾病:果糖摄入和饮食模式的作用。
Nutrients. 2018 Sep 19;10(9):1329. doi: 10.3390/nu10091329.
10
Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring.父母非酒精性脂肪肝疾病会增加后代非酒精性脂肪肝疾病的风险。
Liver Int. 2019 Apr;39(4):740-747. doi: 10.1111/liv.13956. Epub 2018 Sep 25.